 | • レポートコード：MRC2303F0078 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、247ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、2021年に823.54百万ドルであった世界のE. Coli（大腸菌）検査市場規模が、2022年に905.24百万ドルになり、予測期間中（〜2027年）にCAGR10.09%で成長し1,466.70百万ドルまで達すると展望されています。本書は、E. Coli（大腸菌）検査の世界市場について総合的に分析し、市場規模・動向・予測などを整理しています。序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、検査別（臨床、環境）分析、エンドユーザー別（ボトルウォーター供給業者、診断研究室、政府機関、家庭・飲料水供給業者、その他）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成で掲載しています。また、主要企業として、Abbott laboratories、Becton, Dickinson and Company、Bio-Rad Laboratories, Inc.、Biomerica、Bureau Veritas SA、Caisson Laboratories, Inc、Cell Culture Technologies LLC、Corning Incorporated、Enzo Life Sciences, Inc.、Eurofins Scientific、F. Hoffmann-La Roche Ltd.、Fujifilm Holdings Corporation、GE Healthcare、HiMedia Laboratories Pvt., Ltd、HyServe、Idexx Laboratories、Liofilchem S.r.l.、Lonza Group Ltd、Merck & Co., Inc、SGS SA、Thermo Fisher Scientific Inc.などの情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のE. Coli（大腸菌）検査市場規模：検査別 - 臨床における市場規模 - 環境における市場規模 ・世界のE. Coli（大腸菌）検査市場規模：エンドユーザー別 - ボトルウォーター供給業者における市場規模 - 診断研究室における市場規模 - 政府機関における市場規模 - 家庭・飲料水供給業者における市場規模 - その他における市場規模 ・世界のE. Coli（大腸菌）検査市場規模：地域別 - 南北アメリカのE. Coli（大腸菌）検査市場規模 アメリカのE. Coli（大腸菌）検査市場規模 カナダのE. Coli（大腸菌）検査市場規模 ブラジルのE. Coli（大腸菌）検査市場規模 … - アジア太平洋のE. Coli（大腸菌）検査市場規模 日本のE. Coli（大腸菌）検査市場規模 中国のE. Coli（大腸菌）検査市場規模 インドのE. Coli（大腸菌）検査市場規模 韓国のE. Coli（大腸菌）検査市場規模 台湾のE. Coli（大腸菌）検査市場規模 … - ヨーロッパ/中東/アフリカのE. Coli（大腸菌）検査市場規模 イギリスのE. Coli（大腸菌）検査市場規模 ドイツのE. Coli（大腸菌）検査市場規模 フランスのE. Coli（大腸菌）検査市場規模 ロシアのE. Coli（大腸菌）検査市場規模 … - その他地域のE. Coli（大腸菌）検査市場規模 ・競争状況 ・企業情報 |
The Global E. Coli Testing Market size was estimated at USD 823.54 million in 2021 and expected to reach USD 905.24 million in 2022, and is projected to grow at a CAGR 10.09% to reach USD 1,466.70 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the E. Coli Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Testing, the market was studied across Clinical and Environmental. The Clinical is further studied across Enzyme Immunoassays, Polymerase Chain, and Reaction Tests. The Environmental is further studied across Enzyme Substrate Methods, Membrane Filtration, and Multiple Tube Fermentation.
Based on End User, the market was studied across Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies, Home & Drinking Water Suppliers, Hospitals, and Waste Water Treatment Agencies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for E. Coli Testing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the E. Coli Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global E. Coli Testing Market, including Abbott laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica, Bureau Veritas SA, Caisson Laboratories, Inc, Cell Culture Technologies LLC, Corning Incorporated, Enzo Life Sciences, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE Healthcare, HiMedia Laboratories Pvt., Ltd, HyServe, Idexx Laboratories, Liofilchem S.r.l., Lonza Group Ltd, Merck & Co., Inc, SGS SA, and Thermo Fisher Scientific Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global E. Coli Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global E. Coli Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global E. Coli Testing Market?
4. What is the competitive strategic window for opportunities in the Global E. Coli Testing Market?
5. What are the technology trends and regulatory frameworks in the Global E. Coli Testing Market?
6. What is the market share of the leading vendors in the Global E. Coli Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global E. Coli Testing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of diarrhea
5.1.1.2. Growing demand for accurate diagnostic technology
5.1.1.3. Increase in drug-resistant E. coli strains
5.1.1.4. Government initiatives to improve healthcare services
5.1.2. Restraints
5.1.2.1. High Cost of E. coli Treatment
5.1.3. Opportunities
5.1.3.1. Faster & efficient testing with new technologies
5.1.3.2. Strategic collaboration by companies for R&D and product developments
5.1.4. Challenges
5.1.4.1. Limitations of PCR-based pathogen detection
5.1.4.2. Lack of skilled workforce
5.1.4.3. Stringent regulatory environment
5.2. Cumulative Impact of COVID-19
6. E. Coli Testing Market, by Testing
6.1. Introduction
6.2. Clinical
6.3.1. Enzyme Immunoassays
6.3.2. Polymerase Chain
6.3.3. Reaction Tests
6.3. Environmental
6.4.1. Enzyme Substrate Methods
6.4.2. Membrane Filtration
6.4.3. Multiple Tube Fermentation
7. E. Coli Testing Market, by End User
7.1. Introduction
7.2. Bottled Water Suppliers
7.3. Diagnostic Laboratories
7.4. Government Agencies
7.5. Home & Drinking Water Suppliers
7.6. Hospitals
7.7. Waste Water Treatment Agencies
8. Americas E. Coli Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific E. Coli Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa E. Coli Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott laboratories
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Becton, Dickinson and Company
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Biomerica
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Bureau Veritas SA
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Caisson Laboratories, Inc
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Cell Culture Technologies LLC
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Corning Incorporated
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Enzo Life Sciences, Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Eurofins Scientific
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. F. Hoffmann-La Roche Ltd.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Fujifilm Holdings Corporation
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. GE Healthcare
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. HiMedia Laboratories Pvt., Ltd
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. HyServe
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Idexx Laboratories
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Liofilchem S.r.l.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Lonza Group Ltd
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Merck & Co., Inc
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. SGS SA
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Thermo Fisher Scientific Inc.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing